Ella J Loui Magal from 16412 Agate Point Rd NE, Seattle, WA 98110, age 73, Phone: 206 842-5352

view source

Location:

Bainbridge Island, WA

Work:

Magal Louis Gallery 2014 - 2017
Retired

view source

Location:

28363 west Balkins Dr, Agoura Hills, CA 91301

Industry:

Arts And Crafts

Work:

Fine Art Photography 2008 - 2011
Art Director
Louis Photography 2008 - 2011
Owner

Education:

Ben - Gurion University of the Negev 1971 - 1981
Doctorates, Doctor of Philosophy, Biology, Philosophy

Skills:

Contemporary Art

Eck Receptor Ligands
view source
US Patent:

6479250, Nov 12, 2002
Filed:

Jul 7, 2000
Appl. No.:

09/611452
Inventors:

Timothy D. Bartley - Thousand Oaks CA
William J. Boyle - Moorpark CA
Gary M. Fox - Newbury Park CA
Andrew A. Welcher - Glendale CA
Ella Magal - Thousand Oaks CA
Richard A. Lindberg - Thousand Oaks CA
Vann P. Parker - Newbury Park CA
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

C12Q 148
US Classification:

435 15
Abstract:

Ligands which bind to the eck receptor are disclosed. More particularly, polypeptides which bind specifically to the eck receptor (eck receptor binding proteins or EBPs) and DNA sequences encoding said polypeptides are disclosed. Methods of treatment using eck receptor ligands and soluble eck receptor and disclosed, as are pharmaceutical compositions containing same. A rapid and sensitive method for the detection of receptor binding activity in crude samples is provided.

Method For Preventing And Treating Hearing Loss Using Sensorineurotrophic Compounds
view source
US Patent:

20040186098, Sep 23, 2004
Filed:

Mar 29, 2004
Appl. No.:

10/813081
Inventors:

Ella Magal - Thousand Oaks CA, US
Assignee:

Amgen Inc.
International Classification:

A61K031/55
A61K031/54
A61K031/537
A61K031/496
A61K031/445
A61K031/40
A61K031/426
A61K031/421
US Classification:

514/217120, 514/227200, 514/237500, 514/252120, 514/317000, 514/365000, 514/374000, 514/400000, 514/408000
Abstract:

The present invention relates generally to methods for preventing and/or treating injury or degeneration of cochlear hair cells and spiral ganglion neurons by administering sensorineurotrophic compounds described below. The invention relates more specifically to methods for treating sensorineural hearing loss as well as vestibular disorders and tinnitus.

Method For Preventing And Treating Hearing Loss Using A Neuturin Protein Product
view source
US Patent:

60432217, Mar 28, 2000
Filed:

Jun 29, 1998
Appl. No.:

9/106486
Inventors:

Ella Magal - Thousand Oaks CA
John M. Delaney - Newbury Park CA
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

A61K 3800
C07K 500
C07K 700
US Classification:

514 12
Abstract:

The present invention relates generally to methods for preventing and/or treating injury or degeneration of cochlear hair cells and spiral ganglion neurons by administering a neurturin neurotrophic factor protein product. The invention relates more specifically to methods for treating sensorineural hearing loss.

Eck Receptor Ligands
view source
US Patent:

60871679, Jul 11, 2000
Filed:

Oct 28, 1997
Appl. No.:

8/959524
Inventors:

Timothy D. Bartley - Thousand Oaks CA
William J. Boyle - Moorpark CA
Gary M. Fox - Newbury Park CA
Andrew A. Welcher - Glendale CA
Ella Magal - Thousand Oaks CA
Richard A. Lindberg - Thousand Oaks CA
Vann P. Parker - Newbury Park CA
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

C12N 500
C12N 508
C12N 506
A61K 3800
US Classification:

435325
Abstract:

Ligands which bind to the eck receptor are disclosed. More particularly, polypeptides which bind specifically to the eck receptor (eck receptor binding proteins or EBPs) and DNA sequences encoding said polypeptides are disclosed. Methods of treatment using eck receptor ligands and soluble eck receptor and disclosed, as are pharmaceutical compositions containing same. A rapid and sensitive method for the detection of receptor binding activity in crude samples is provided.

Method For Treating Sensorineural Hearing Loss Using Glial Cell Line-Derived Neurotrophic Factor (Gdnf) Protein Product
view source
US Patent:

58376810, Nov 17, 1998
Filed:

Feb 23, 1996
Appl. No.:

8/606176
Inventors:

Ella Magal - Thousand Oaks CA
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

C12N 1512
A61K 3818
US Classification:

514 12
Abstract:

The present invention relates generally to methods for preventing and/or treating injury or degeneration of cochlear hair cells and spiral ganglion neurons by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates more specifically to methods for treating sensorineural hearing loss.

Method For Preventing And Treating Sensorineural Hearing Loss And Vestibular Disorders Using Glial Cell Line-Derived Neurotrophic Factor(Gdnf) Protein Product
view source
US Patent:

59290412, Jul 27, 1999
Filed:

Sep 13, 1996
Appl. No.:

8/710219
Inventors:

Ella Magal - Thousand Oaks CA
Assignee:

Amgen Inc. - Thousand Okas CA
International Classification:

A01N 6300
A01N 3718
A61K 3800
A61K 4800
US Classification:

514 44
Abstract:

The present invention relates generally to methods for preventing and/or treating injury or degeneration of cochlear (and vestibular) hair cells and spiral ganglion neurons (as well as vestibular neurons--Carpa's neurons) by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates more specifically to methods for treating sensorineural hearing loss and vestibular disorders.

Eck Receptor Ligands
view source
US Patent:

58243038, Oct 20, 1998
Filed:

May 19, 1995
Appl. No.:

8/445065
Inventors:

Timothy D. Bartley - Thousand Oaks CA
William J. Boyle - Moorpark CA
Gary M. Fox - Newbury Park CA
Andrew A. Welcher - Glendale CA
Ella Magal - Thousand Oaks CA
Richard A. Lindberg - Thousand Oaks CA
Vann P. Parker - Newbury Park CA
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

A61K 3845
A61K 3800
C12N 912
US Classification:

424 945
Abstract:

Ligands which bind to the eck receptor are disclosed. More particularly, polypeptides which bind specifically to the eck receptor (eck receptor binding proteins or EBPs) and DNA sequences encoding said polypeptides are disclosed. Methods of treatment using eck receptor ligands and soluble eck receptor and disclosed, as are pharmaceutical compositions containing same. A rapid and sensitive method for the detection of receptor binding activity in crude samples is provided.

Method For Preventing And Treating Hearing Loss Using A Neurturin Protein Product
view source
US Patent:

62745549, Aug 14, 2001
Filed:

Aug 19, 1999
Appl. No.:

9/377446
Inventors:

Ella Magal - Thousand Oaks CA
John M. Delaney - Newbury Park CA
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

A61K 3800
C07K 100
C07K 200
C07K 400
C07K 500
US Classification:

514 12
Abstract:

The present invention relates generally to methods for preventing and/or treating injury or degeneration of cochlear hair cells and spiral ganglion neurons by administering a neurturin neurotrophic factor protein product. The invention relates more specifically to methods for treating sensorineural hearing loss.

Ella J Loui Magal